About this trial
This study will verify the 1-channel patch-type ECG's arrhythmia diagnostic concordance rate and electrocardiogram measurement performance in pediatric patients by collecting ECG signals from patch-type ECG and Holter device simultaneously for data analysis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
More than 29 days old and less than 19 years old
Patients who are need regular Holter electrocardiography among outpatients or hospitalized patients at the Pediatrics, Samsung Medical Center
Those who gave written consent to this clinical study or obtained the written consent of the legal representative
Disqualifiers
Patients who cannot give consent through the patient ownself or legal representative
If the researcher judges that participation in this study is inappropriate for other reasons
Trial design
Single group
Treatments tested in this trial
Electrocardiogram measurements by holter device and patch-type electrocardiographic at the same time
DeviceThe patient is measured electrocardiogram simultaneously through a holter device and patch-type electrocardiograph
Treatment groups
Trial outcomes
Primary outcomes
Rate of arrhythmia diagnosis between patch-type electrocardiograph and commercial Holter device measurement data by arrhythmia categories
Rate of arrhythmia diagnosis between 24-hour patch-type electrocardiograph and commercial Holter device measurement data by arrhythmia categories(total of 19 including ventricular ectopic beat)
Rate of ECG signal concordance between patch-type electrocardiograph and holter device
Calculate the concordance (%) of the ECG signal by comparing and analyzing total QRS complex, total ventricular ectopic beats, total atrial ectopic beats, minimum heart rate(bpm), maximum heart rate(bpm), average heart rate(bpm) and maximum RR interval(ms)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.